{"title":"AGE-RELATED CHANGES OF HORMONAL HOMEOSTASIS IN POLYCYSTOSIS \nOF OVARIANS","authors":"Sain Safarova Sain Safarova","doi":"10.55858/ijimh01022022-28","DOIUrl":null,"url":null,"abstract":"Violation of hormonal homeostasis in polycystic ovary syndrome (PCOS) causes a number of changes in the body of a woman in the postmenopausal period. One of the clinical features of the climacteric syndrome in PCOS is the presence of rare and weak hot flashes, a decrease in the menopausal peak of gonadotropins, and a distinct appearance of local urogenital symptoms. With age, in women with PCOS, a history of insulin resistance and dyslipidaemia predisposes them to early onset of cardiovascular disease and type 2 diabetes. Pathogenetic treatment of women with a history of PCOS in the postmenopausal period should be carried out in order to prevent atherosclerotic and metabolic complications.\nKeywords: postmenopause, polycystic ovary syndrome, insulin resistance","PeriodicalId":204122,"journal":{"name":"INTERNATIONAL JOURNAL OF INNOVATIVE MEDICINE & HEALTHCARE","volume":"17 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"INTERNATIONAL JOURNAL OF INNOVATIVE MEDICINE & HEALTHCARE","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55858/ijimh01022022-28","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Violation of hormonal homeostasis in polycystic ovary syndrome (PCOS) causes a number of changes in the body of a woman in the postmenopausal period. One of the clinical features of the climacteric syndrome in PCOS is the presence of rare and weak hot flashes, a decrease in the menopausal peak of gonadotropins, and a distinct appearance of local urogenital symptoms. With age, in women with PCOS, a history of insulin resistance and dyslipidaemia predisposes them to early onset of cardiovascular disease and type 2 diabetes. Pathogenetic treatment of women with a history of PCOS in the postmenopausal period should be carried out in order to prevent atherosclerotic and metabolic complications.
Keywords: postmenopause, polycystic ovary syndrome, insulin resistance